Selective expression of folate receptor β and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis
…, N Sunahara, T Nakamura, M Tsukano… - … : Official Journal of …, 1999 - Wiley Online Library
Objective To investigate the expression of folate receptors (FR) and reduced folate carrier (RFC)
and determine their relevance to methotrexate (MTX) transport in synovial mononuclear …
and determine their relevance to methotrexate (MTX) transport in synovial mononuclear …
Polyarteritis nodosa limited to calf muscles: a case report and review of the literature
T Nakamura, K Tomoda, Y Yamamura, M Tsukano… - Clinical …, 2003 - Springer
We describe an unusual case of a 38-year-old woman with a localised form of polyarteritis
nodosa (PAN) manifested by acute onset of severe calf pain. Magnetic resonance imaging of …
nodosa (PAN) manifested by acute onset of severe calf pain. Magnetic resonance imaging of …
Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts
…, SY Dai, S Katoh, N Nishi, M Tsukano… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To compare the expression of galectin 9 (Gal‐9) in synovial tissue (ST) from
rheumatoid arthritis (RA) patients and osteoarthritis (OA) patients and to evaluate the effects of Gal…
rheumatoid arthritis (RA) patients and osteoarthritis (OA) patients and to evaluate the effects of Gal…
[HTML][HTML] Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis
T Okada, H Tsukano, M Endo, M Tabata… - The American journal of …, 2010 - Elsevier
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by symmetrical
polyarticular synovitis of the diarthrodial joints. Several proinflammatory cytokines derived from …
polyarticular synovitis of the diarthrodial joints. Several proinflammatory cytokines derived from …
Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis …
…, S Nagaoka, T Hidaka, T Atsumi, M Tsukano… - The Journal of …, 2011 - jrheum.org
Objective. The aim of the Efficacy and Safety of Etanercept on Active Rheumatoid Arthritis
Despite Methotrexate Therapy in Japan (JESMR) study is to compare the efficacy of …
Despite Methotrexate Therapy in Japan (JESMR) study is to compare the efficacy of …
Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: results from a randomized …
…, W Park, K Shiozawa, M Tsukano… - Modern …, 2016 - academic.oup.com
Objectives: This phase II, dose-ranging, double-blind, placebo-controlled, randomized study
(NCT01463059) evaluated efficacy and safety of olokizumab (OKZ), a humanized anti-…
(NCT01463059) evaluated efficacy and safety of olokizumab (OKZ), a humanized anti-…
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial
…, T Hidaka, T Atsumi, M Tsukano… - Modern …, 2010 - academic.oup.com
The superiority of the combination therapy of methotrexate (MTX) and anti-tumor necrosis
factor (TNF) biological agents over anti-TNF monotherapy in MTX-naïve patients with …
factor (TNF) biological agents over anti-TNF monotherapy in MTX-naïve patients with …
Mycobacterium kansasii arthritis of the foot in a patient with systemic lupus erythematosus
…, K Tomoda, M SAKAGUCHI, M TSUKANO - Internal …, 2001 - jstage.jst.go.jp
Mycobacteriumkansasii, an atypical Mycobacterium, may cause serious illness in humans.
Wedescribe a M. kansasii infection of the foot joint, which was diagnosed in a 46-year-old …
Wedescribe a M. kansasii infection of the foot joint, which was diagnosed in a 46-year-old …
Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis
T Nakamura, S Higashi, K Tomoda, M Tsukano… - Clinical …, 2010 - Springer
The benefit of biological therapies in rheumatoid arthritis (RA) treatment is well known, but
their role in amyloid A (AA) amyloidosis secondary to RA is unclear. The aim of this study was …
their role in amyloid A (AA) amyloidosis secondary to RA is unclear. The aim of this study was …
Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis
T Nakamura, S Higashi, K Tomoda, M Tsukano… - …, 2012 - academic.oup.com
Objectives. To compare the effectiveness of an alkylating agent with that of a biologic agent
in the treatment of patients with amyloid A (AA) amyloidosis secondary to RA and to assess …
in the treatment of patients with amyloid A (AA) amyloidosis secondary to RA and to assess …